Skip to main content
OpenTrials

Clinical trial condition

Sezary Syndrome

Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.

262 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Sezary Syndrome trial results

Completed

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

NCT00071084

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Stanford University Med Ctr., Dept of Dermatology Stanford, California, United States
  • University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
  • Münster, Germany
  • Stockholm, Sweden
View Trial Details
Completed

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00416351

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

NCT00425555

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Dept. of Hematology-Oncology Los Angeles, California, United States
  • Florida Academic Dermatology Center Miami, Florida, United States
View all 42 locations
View Trial Details

Related conditions